Literature DB >> 33358080

The relationship between kidney function and body mass index before and after bariatric surgery in patients with chronic kidney disease.

Heidi Fischer1, Robert E Weiss2, Allon N Friedman3, Talha H Imam4, Karen J Coleman5.   

Abstract

BACKGROUND: Improvements in kidney function post-bariatric surgery may be related to weight loss-independent effects.
OBJECTIVES: To characterize the dynamic relationship between body mass index (BMI) and estimated glomerular filtration rate (eGFR) before and after bariatric surgery in patients with chronic kidney disease (CKD).
SETTING: Kaiser Permanente Southern California (KPSC) health system.
METHODS: We conducted an observational, retrospective cohort study of patients with CKD stage 3 or higher who received bariatric surgery at the KPSC health system between 2007-2015. Bariatric surgery procedures included primary Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) procedures. Outcomes consisted of mean trajectory estimates and correlations of BMI and eGFR taken between 2 years before and 3 years after surgery. Multivariate functional mixed models were used to estimate how BMI and eGFR trajectories evolved jointly.
RESULTS: A total of 619 RYGB and 474 SG patients were included in the final analytic sample. The measurements were available before surgery for a median time of 1.9 years for SG and 1.8 years for RYGB patients. Median follow-up times after surgery were 2.8 years for both SG and RYGB patients. The mean age at the time of surgery was 58 years; 77% of patients were women; 56% of patients were non-Hispanic White; the mean BMI was 44 kg/m2; 60% of patients had diabetes mellitus; and 84% of patients had hypertension. Compared to the presurgery eGFR declines, the postsurgery declines in eGFR were 57% slower (95% credible interval [CrI], 33%-81%) for RYGB patients and 55% slower (95% CrI, 25%-75%) for SG patients. The mean correlation between BMI and eGFR was negligible at all time points.
CONCLUSION: Though bariatric surgery slowed declines in eGFR up to 3 years after surgery, changes in eGFR tracked poorly with changes in BMI. This study provides evidence that the kidney-related benefits of bariatric surgery may be at least partly independent of weight loss. Confirming this hypothesis could lead to mechanistic insights and new treatment options for CKD.
Copyright © 2020 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bariatric surgery; Chronic kidney disease; Glomerular filtration rate; Obesity

Mesh:

Year:  2020        PMID: 33358080      PMCID: PMC7904605          DOI: 10.1016/j.soard.2020.11.010

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  37 in total

1.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

Authors:  E J Lewis; L G Hunsicker; W R Clarke; T Berl; M A Pohl; J B Lewis; E Ritz; R C Atkins; R Rohde; I Raz
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

2.  Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes.

Authors:  Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Ali Aminian; Stacy A Brethauer; Sankar D Navaneethan; Rishi P Singh; Claire E Pothier; Steven E Nissen; Sangeeta R Kashyap
Journal:  N Engl J Med       Date:  2017-02-16       Impact factor: 91.245

3.  Three-year weight outcomes from a bariatric surgery registry in a large integrated healthcare system.

Authors:  Karen J Coleman; Yii-Chieh Huang; Fadi Hendee; Heather L Watson; Robert A Casillas; John Brookey
Journal:  Surg Obes Relat Dis       Date:  2014-03-14       Impact factor: 4.734

4.  Estimated GFR Before and After Bariatric Surgery in CKD.

Authors:  Talha H Imam; Heidi Fischer; Bocheng Jing; Raoul Burchette; Shayna Henry; Stephen F DeRose; Karen J Coleman
Journal:  Am J Kidney Dis       Date:  2016-12-04       Impact factor: 8.860

5.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

Authors:  B M Brenner; M E Cooper; D de Zeeuw; W F Keane; W E Mitch; H H Parving; G Remuzzi; S M Snapinn; Z Zhang; S Shahinfar
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

6.  The Association Between Kidney Disease and Diabetes Remission in Bariatric Surgery Patients With Type 2 Diabetes.

Authors:  Allon N Friedman; Junyao Wang; Abdus S Wahed; Neil G Docherty; Erin Fennern; Alfons Pomp; Jonathan Q Purnell; Carel W le Roux; Bruce Wolfe
Journal:  Am J Kidney Dis       Date:  2019-07-19       Impact factor: 8.860

7.  Effect of Roux-en-Y gastric bypass and diet-induced weight loss on diabetic kidney disease in the Zucker diabetic fatty rat.

Authors:  Karl J Neff; Jessie A Elliott; Caroline Corteville; Kathrin Abegg; Camilo Boza; Thomas A Lutz; Neil G Docherty; Carel W le Roux
Journal:  Surg Obes Relat Dis       Date:  2016-08-18       Impact factor: 4.734

8.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

9.  Comparing the 5-Year Diabetes Outcomes of Sleeve Gastrectomy and Gastric Bypass: The National Patient-Centered Clinical Research Network (PCORNet) Bariatric Study.

Authors:  Kathleen M McTigue; Robert Wellman; Elizabeth Nauman; Jane Anau; R Yates Coley; Alberto Odor; Julie Tice; Karen J Coleman; Anita Courcoulas; Roy E Pardee; Sengwee Toh; Cheri D Janning; Neely Williams; Andrea Cook; Jessica L Sturtevant; Casie Horgan; David Arterburn
Journal:  JAMA Surg       Date:  2020-05-20       Impact factor: 14.766

10.  What do I do with my morbidly obese patient? A detailed case study of bariatric surgery in kaiser permanente southern california.

Authors:  Pouya Shafipour; Jack K Der-Sarkissian; Fadi N Hendee; Karen J Coleman
Journal:  Perm J       Date:  2009
View more
  1 in total

Review 1.  Management of Obesity in Adults with CKD.

Authors:  Allon N Friedman; Lee M Kaplan; Carel W le Roux; Philip R Schauer
Journal:  J Am Soc Nephrol       Date:  2021-02-18       Impact factor: 10.121

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.